145 related articles for article (PubMed ID: 38053423)
1. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention.
Wu T; Zhang Z; Huang H; Wu X
Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
3. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
4. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
6. Construction and Bioinformatics Analysis of the miRNA-mRNA Regulatory Network in Diabetic Nephropathy.
Li Y; Xu Y; Hou Y; Li R
J Healthc Eng; 2021; 2021():8161701. PubMed ID: 34840704
[TBL] [Abstract][Full Text] [Related]
7. Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy.
Wang N; Ding L; Liu D; Zhang Q; Zheng G; Xia X; Xiong S
Front Endocrinol (Lausanne); 2022; 13():918605. PubMed ID: 35957838
[TBL] [Abstract][Full Text] [Related]
8. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
Cao H; Rao X; Jia J; Yan T; Li D
Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
[TBL] [Abstract][Full Text] [Related]
9. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
11. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
[TBL] [Abstract][Full Text] [Related]
12. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y
J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482
[TBL] [Abstract][Full Text] [Related]
13. Construction of a TF-miRNA-mRNA Regulatory Network for Diabetic Nephropathy.
Dong F; Zheng L; Yang G
Arch Esp Urol; 2024 Jan; 77(1):104-112. PubMed ID: 38374020
[TBL] [Abstract][Full Text] [Related]
14. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.
Li Y; Wang L; Xu B; Zhao L; Li L; Xu K; Tang A; Zhou S; Song L; Zhang X; Zhan H
J Diabetes Res; 2021; 2021():8891093. PubMed ID: 33628839
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
[TBL] [Abstract][Full Text] [Related]
18. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
Chen S; Chen L; Jiang H
Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the gene expression profile of the male and female BTBR mice with diabetic nephropathy.
Xue R; Wang Y; Geng L; Xiao H; Kumar V; Lan X; Malhotra A; Singhal PC; Chen J
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128720. PubMed ID: 38101684
[TBL] [Abstract][Full Text] [Related]
20. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
